Type 1 Diabetes Trial, Recruiting NCT06876207 Sponsor: Bruno Bombaci Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT06876207
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with type 1 diabetes according to recognised international guidelines for children and adolescents
  • People who have had diabetes for more than 12 months
  • People who are under 20 years old
  • People who have fully completed puberty, as assessed using the Tanner staging system (confirm with trial site)
  • People who have been using a diabetes management system called Control-IQ technology for at least 3 months
  • People whose Control-IQ system has been running in automatic mode for at least 70% of the time during the 2 weeks before joining the trial
  • People who have been wearing a continuous glucose monitor (CGM) — a device that tracks blood sugar levels throughout the day — for at least 70% of the time during the 2 weeks before joining the trial
  • People who already do regular physical activity, meaning at least 2 exercise sessions per week, with each session lasting at least 45 minutes

Who may not be able to join:

  • People with celiac disease or thyroid disease that is not well controlled
  • People who have other ongoing (chronic) health conditions
  • People with psychiatric or neurological conditions, including eating disorders, that could interfere with the study
  • People who regularly take medications (other than insulin) that may affect blood sugar levels
  • People who regularly use substances or drugs that could affect how accurately the CGM works

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393473931038

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Bruno Bombaci
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
31 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Time in range (%); Time in tight range (%); Time above range level 1 (%); Time above range level 2 (%); Time below range level 1 (%); Time below range level 2 (%); Mean sensor glucose (mg/dl or mmol/L); Coefficient of variation (%)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov